XORTX Therapeutics Inc. (XRTX)
XRTX Stock Price Chart
Explore XORTX Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze XRTX price movements and trends.
XRTX Company Profile
Discover essential business fundamentals and corporate details for XORTX Therapeutics Inc. (XRTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Sept 2021
Employees
2.00
Website
https://www.xortx.comCEO
Allen Warren Davidoff
Description
XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program designed to address autosomal dominant polycystic kidney disease (ADPKD). Another key candidate is XRx-101, an agent aimed at reducing uric acid levels in COVID-19 patients, with the goal of mitigating acute kidney injury and related complications. Furthermore, they are developing XRx-221, a series of xanthine oxidase inhibitors intended for the management of diabetic nephropathy. XORTX also collaborates with the Icahn School of Medicine on research investigating acute kidney injury and hyperuricemia among hospitalized COVID-19 patients. The company's operations are headquartered in Vancouver, Canada.
XRTX Financial Timeline
Browse a chronological timeline of XORTX Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
Earnings released on 19 May 2026
EPS came in at -$0.58 .
Stock split effective on 6 Apr 2026
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Feb 2026
EPS came in at -$0.45 surpassing the estimated -$0.84 by +46.14%.
Earnings released on 14 Nov 2025
EPS came in at -$0.13 surpassing the estimated -$0.17 by +22.20%.
Earnings released on 14 Aug 2025
EPS came in at -$0.19 surpassing the estimated -$0.25 by +24.00%.
Earnings released on 19 May 2025
EPS came in at -$0.19 surpassing the estimated -$0.27 by +29.63%.
Earnings released on 15 May 2025
EPS came in at -$0.19 surpassing the estimated -$0.29 by +34.48%.
Earnings released on 14 Nov 2024
EPS came in at -$0.20 surpassing the estimated -$0.38 by +47.80%.
Earnings released on 14 Aug 2024
EPS came in at $0.06 surpassing the estimated -$0.50 by +111.98%.
Earnings released on 15 May 2024
EPS came in at -$1.24 falling short of the estimated -$0.45 by -176.54%.
Earnings released on 2 Apr 2024
EPS came in at -$0.48 surpassing the estimated -$0.68 by +29.00%.
Earnings released on 14 Nov 2023
EPS came in at -$6.03 falling short of the estimated -$2.04 by -195.50%.
Stock split effective on 14 Nov 2023
Shares were split 1 : 9 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2023
EPS came in at -$0.81 surpassing the estimated -$1.56 by +47.98%.
Earnings released on 15 May 2023
EPS came in at -$0.99 surpassing the estimated -$1.31 by +24.44%.
Earnings released on 31 Mar 2023
EPS came in at -$1.35 surpassing the estimated -$2.18 by +38.03%.
Earnings released on 10 Nov 2022
EPS came in at -$0.81 surpassing the estimated -$1.54 by +47.31%.
Earnings released on 11 Aug 2022
EPS came in at -$0.81 falling short of the estimated -$0.24 by -237.50%.
Earnings released on 13 May 2022
EPS came in at -$0.72 surpassing the estimated -$1.49 by +51.77%.
Earnings released on 31 Dec 2021
EPS came in at $5.21 .
Earnings released on 29 Nov 2021
EPS came in at -$157.00 .
Stock split effective on 23 Sept 2021
Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 27 Aug 2021
EPS came in at -$5.25 .
XRTX Stock Performance
Access detailed XRTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
